Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages

Abstract

Dysbiosis of the gut microbiota has been implicated in hypertension, and drug–host–microbiome interactions have drawn considerable attention. However, the influence of angiotensin receptor blocker (ARB)-shaped gut microbiota on the host is not fully understood. In this work, we assessed the alterations of blood pressure (BP), vasculatures, and intestines following ARB-modified gut microbiome treatment and evaluated the changes in the intestinal transcriptome and serum metabolome in hypertensive rats. Hypertensive patients with well-controlled BP under ARB therapy were recruited as human donors, spontaneously hypertensive rats (SHRs) receiving normal saline or valsartan were considered animal donors, and SHRs were regarded as recipients. Histological and immunofluorescence staining was used to assess the aorta and small intestine, and 16S rRNA amplicon sequencing was performed to examine gut bacteria. Transcriptome and metabonomic analyses were conducted to determine the intestinal transcriptome and serum metabolome, respectively. Notably, ARB-modified fecal microbiota transplantation (FMT), results in marked decreases in systolic BP levels, collagen deposition and reactive oxygen species accumulation in the vasculature, and alleviated intestinal structure impairments in SHRs. These changes were linked with the reconstruction of the gut microbiota in SHR recipients post-FMT, especially with a decreased abundance of Lactobacillus, Aggregatibacter, and Desulfovibrio. Moreover, ARB-treated microbes contributed to increased intestinal Ciart, Per1, Per2, Per3, and Cipc gene levels and decreased Nfil3 and Arntl expression were detected in response to ARB-treated microbes. More importantly, circulating metabolites were dramatically reduced in ARB-FMT rats, including 6beta-Hydroxytestosterone and Thromboxane B2. In conclusion, ARB-modified gut microbiota exerts protective roles in vascular remodeling and injury, metabolic abnormality and intestinal dysfunctions, suggesting a pivotal role in mitigating hypertension and providing insights into the cross-talk between antihypertensive medicines and the gut microbiome.

Keywords

angiotensin receptor blockers / antihypertensive / gut microbiota / hypertension / vascular injury

References

[1] Saladini, Francesca, Costantino Mancusi, Fabio Bertacchini, Francesco Spannella, Alessandro Maloberti, Alessandra Giavarini, and Martina Rosticci, et al. 2020. “Diagnosis and Treatment of Hypertensive Emergencies and Urgencies Among Italian Emergency and Intensive Care Departments. Results From an Italian Survey: Progetto GEAR (Gestione Dell'emergenza E Urgenza in ARea Critica).” European Journal of Internal Medicine 71: 50-56. https://doi.org/10.1016/j.ejim.2019.10.004

[2] Zhou, Bin, James Bentham, Mariachiara Di Cesare, Honor Bixby, Goodarz Danaei, Melanie J. Cowan, and Christopher J. Paciorek, et al. 2017. “Worldwide Trends in Blood Pressure from 1975 to 2015: A Pooled Analysis of 1479 Population-Based Measurement Studies with 19·1 Million Participants.” The Lancet 389: 37-55. https://doi.org/10.1016/s0140-6736(16)31919-5

[3] Wang, Zengwu, Zuo Chen, Linfeng Zhang, Xin Wang, Guang Hao, Zugui Zhang, Lan Shao, et al. 2018. “Status of Hypertension in China: Results From the China Hypertension Survey, 2012−2015.” Circulation 137: 2344-2356. https://doi.org/10.1161/circulationaha.117.032380

[4] Li, Jing, Fangqing Zhao, Yidan Wang, Junru Chen, Jie Tao, Gang Tian, Shouling Wu, et al. 2017. “Gut Microbiota Dysbiosis Contributes to the Development of Hypertension.” Microbiome 5: 14. https://doi.org/10.1186/s40168-016-0222-x

[5] Li, Jing, Qiannan Gao, Yiyangzi Ma, Yue Deng, Shuangyue Li, Na Shi, Haitao Niu, Xin-Yu Liu, and Jun Cai. 2022. “Causality of Opportunistic Pathogen Klebsiella Pneumoniae to Hypertension Development.” Hypertension 79: 2743-2754. https://doi.org/10.1161/hypertensionaha.122.18878

[6] Avery, Ellen G., Hendrik Bartolomaeus, Ariana Rauch, Chia-Yu Chen, Gabriele N'Diaye, Ulrike Löber, Theda U. P. Bartolomaeus, et al. 2023. “Quantifying the Impact of Gut Microbiota on Inflammation and Hypertensive Organ Damage.” Cardiovascular Research 119: 1441-1452. https://doi.org/10.1093/cvr/cvac121

[7] Dinakis, Evany, Michael Nakai, Paul Gill, Rosilene Ribeiro, Stephanie Yiallourou, Yusuke Sata, Jane Muir, et al. 2022. “Association Between the Gut Microbiome and Their Metabolites With Human Blood Pressure Variability.” Hypertension 79: 1690-1701. https://doi.org/10.1161/hypertensionaha.122.19350

[8] Wilck, Nicola, Mariana G. Matus, Sean M. Kearney, Scott W. Olesen, Kristoffer Forslund, Hendrik Bartolomaeus, Stefanie Haase, et al. 2017. “Salt-Responsive Gut Commensal Modulates T(H)17 Axis and Disease.” Nature 551: 585-589. https://doi.org/10.1038/nature24628

[9] Hirano, Emi, Noriko Sugita, Akira Kikuchi, Yasuko Shimada, Jun Sasahara, Ruriko Iwanaga, Kenichi Tanaka, and Hiromasa Yoshie. 2012. “The Association of Aggregatibacter Actinomycetemcomitans with Preeclampsia in a Subset of Japanese Pregnant Women.” Journal of Clinical Periodontology 39: 229-238. https://doi.org/10.1111/j.1600-051x.2011.01845.x

[10] Petriz, Bernardo A., Alinne P. Castro, Jeeser A. Almeida, Clarissa Pc Gomes, Gabriel R. Fernandes, Ricardo H. Kruger, Rinaldo W. Pereira, and Octavio L. Franco. 2014. “Exercise Induction of Gut Microbiota Modifications in Obese, Non-Obese and Hypertensive Rats.” BMC Genomics 15: 511. https://doi.org/10.1186/1471-2164-15-511

[11] Andújar-Tenorio, Natalia, Isabel Prieto, Antonio Cobo, Ana M. Martínez-Rodríguez, Marina Hidalgo, Ana Belén Segarra, Manuel Ramírez, Antonio Gálvez, and Magdalena Martínez-Cañamero. 2022. “High Fat Diets Induce Early Changes in Gut Microbiota That May Serve As Markers of Ulterior Altered Physiological and Biochemical Parameters Related to Metabolic Syndrome. Effect of Virgin Olive Oil in Comparison to Butter.” PLoS One 17: e0271634. https://doi.org/10.1371/journal.pone.0271634

[12] Olid, María Collado, Marina Hidalgo, Isabel Prieto, Antonio Cobo, Ana M. Martínez-Rodríguez, Ana Belén Segarra, Manuel Ramírez-Sánchez, Antonio Gálvez, and Magdalena Martínez-Cañamero. 2023. “Evidence Supporting the Involvement of the Minority Compounds of Extra Virgin Olive Oil, through Gut Microbiota Modulation, in Some of the Dietary Benefits Related to Metabolic Syndrome in Comparison to Butter.” Molecules 28: 2265. https://doi.org/10.3390/molecules28052265

[13] Yan, Xiaoyan, Xushen Chen, Xiaolin Tian, Yulan Qiu, Jie Wang, Guan Yu, Nisha Dong, et al. 2021. “Co-Exposure to Inorganic Arsenic and Fluoride Prominently Disrupts Gut Microbiota Equilibrium and Induces Adverse Cardiovascular Effects in Offspring Rats.” Science of the Total Environment 767: 144924. https://doi.org/10.1016/j.scitotenv.2020.144924

[14] Xia, Wen-Jie, Meng-Lu Xu, Xiao-Jing Yu, Meng-Meng Du, Xu-Hui Li, Tao Yang, Lu Li, et al. 2021. “Antihypertensive Effects of Exercise Involve Reshaping of Gut Microbiota and Improvement of Gut-Brain Axis in Spontaneously Hypertensive Rat.” Gut Microbes 13: 1-24. https://doi.org/10.1080/19490976.2020.1854642

[15] Wang, Yiqing, Huijun Wang, Annie Green Howard, Matthew C. B. Tsilimigras, Christy L. Avery, Katie A. Meyer, Wei Sha, et al. 2021. “Gut Microbiota and Host Plasma Metabolites in Association with Blood Pressure in Chinese Adults.” Hypertension 77: 706-717. https://doi.org/10.1161/hypertensionaha.120.16154

[16] Thingholm, Louise B., Malte C. Rühlemann, Manja Koch, Brie Fuqua, Guido Laucke, Ruwen Boehm, and Corinna Bang, et al. 2019. “Obese Individuals with and Without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and Composition.” Cell Host & Microbe 26: 252-264. https://doi.org/10.1016/j.chom.2019.07.004

[17] Tan, Nian-Di, Yun Qiu, Xiang-Bin Xing, Subrata Ghosh, Min-Hu Chen, and Ren Mao. 2020. “Associations Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blocker Use, Gastrointestinal Symptoms, and Mortality Among Patients With COVID-19.” Gastroenterology 159: 1170-1172.e1171. https://doi.org/10.1053/j.gastro.2020.05.034

[18] Qi, Ying-Zi, Yue-Hua Jiang, Ling-Yu Jiang, Lin-Lin Shao, Xue-Song Yang, and Chuan-Hua Yang. 2021. “An Insight Into Intestinal Microbiota of Spontaneously Hypertensive Rats After Valsartan Administration.” Dose-Response 19: 15593258211011342. https://doi.org/10.1177/15593258211011342

[19] Dong, Ying, Pan Wang, Jie Jiao, Xinchun Yang, Mulei Chen, and Jing Li. 2022. “Antihypertensive Therapy by ACEI/ARB Is Associated With Intestinal Flora Alterations and Metabolomic Profiles in Hypertensive Patients.” Frontiers in Cell and Developmental Biology 10: 861829. https://doi.org/10.3389/fcell.2022.861829

[20] Liu, Ye, Yan Duan, Nan Zhao, Xinxin Zhu, Xiaoting Yu, Shiyu Jiao, Yanting Song, et al. 2022. “Peroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production.” Antioxidants 11: 2378. https://doi.org/10.3390/antiox11122378

[21] Yang, Tao, Monica M. Santisteban, Vermali Rodriguez, Eric Li, Niousha Ahmari, Jessica Marulanda Carvajal, Mojgan Zadeh, et al. 2015. “Gut Dysbiosis is Linked to Hypertension.” Hypertension 65: 1331-1340. https://doi.org/10.1161/hypertensionaha.115.05315

[22] Zuo, Kun, Jing Li, Pan Wang, Ye Liu, Zheng Liu, Xiandong Yin, Xiaoqing Liu, and Xinchun Yang. 2019. “Duration of Persistent Atrial Fibrillation Is Associated with Alterations in Human Gut Microbiota and Metabolic Phenotypes.” mSystems 4: 10-1128. https://doi.org/10.1128/mSystems.00422-19

[23] Moreno-Gallego, J. Leonardo, Shao-Pei Chou, Sara C. Di Rienzi, Julia K. Goodrich, Timothy D. Spector, Jordana T. Bell, and Nicholas D. Youngblut, et al. 2019. “Virome Diversity Correlates with Intestinal Microbiome Diversity in Adult Monozygotic Twins.” Cell Host & Microbe 25: 261-272. https://doi.org/10.1016/j.chom.2019.01.019

[24] Santisteban, Monica M., Yanfei Qi, Jasenka Zubcevic, Seungbum Kim, Tao Yang, Vinayak Shenoy, Colleen T. Cole-Jeffrey, et al. 2017. “Hypertension-Linked Pathophysiological Alterations in the Gut.” Circulation Research 120: 312-323. https://doi.org/10.1161/circresaha.116.309006

[25] Walsh, Jacinta, Brendan T. Griffin, Gerard Clarke, and Niall P. Hyland. 2018. “Drug-Gut Microbiota Interactions: Implications for Neuropharmacology.” British Journal of Pharmacology 175: 4415-4429. https://doi.org/10.1111/bph.14366

[26] Tintelnot, Joseph, Yang Xu, Till R. Lesker, Martin Schönlein, Leonie Konczalla, Anastasios D. Giannou, Penelope Pelczar, et al. 2023. “Microbiota-Derived 3-IAA Influences Chemotherapy Efficacy in Pancreatic Cancer.” Nature 615: 168-174. https://doi.org/10.1038/s41586-023-05728-y

[27] Stein-Thoeringer, Christoph K., Neeraj Y. Saini, Eli Zamir, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Matthias A. Fante, et al. 2023. “A Non-Antibiotic-Disrupted Gut Microbiome Is Associated with Clinical Responses to CD19-CAR-T Cell Cancer Immunotherapy.” Nature Medicine 29: 906-916. https://doi.org/10.1038/s41591-023-02234-6

[28] Wu, Chongming, Ying Zhao, Yingying Zhang, Yanan Yang, Wenquan Su, Yuanyuan Yang, Le Sun, et al. 2022. “Gut Microbiota Specifically Mediates the Anti-Hypercholesterolemic Effect of Berberine (BBR) and Facilitates to Predict BBR's Cholesterol-Decreasing Efficacy in Patients.” Journal of Advanced Research 37: 197-208. https://doi.org/10.1016/j.jare.2021.07.011

[29] Mehta, Raaj S., Jared R. Mayers, Yancong Zhang, Amrisha Bhosle, Nathaniel R. Glasser, Long H. Nguyen, Wenjie Ma, et al. 2023. “Gut Microbial Metabolism of 5-ASA Diminishes Its Clinical Efficacy in Inflammatory Bowel Disease.” Nature Medicine 29: 700-709. https://doi.org/10.1038/s41591-023-02217-7

[30] Robles-Vera, Iñaki, Marta Toral, Néstor de la Visitación, Manuel Sánchez, Manuel Gómez-Guzmán, Raquel Muñoz, Francesca Algieri, et al. 2020. “Changes to the Gut Microbiota Induced By Losartan Contributes to its Antihypertensive Effects.” British Journal of Pharmacology 177: 2006-2023. https://doi.org/10.1111/bph.14965

[31] Yang, Tao, Xue Mei, Ethel Tackie-Yarboi, Millicent Tambari Akere, Jun Kyoung, Blair Mell, Ji-Youn Yeo, et al. 2022. “Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors.” Hypertension 79: 1591-1601. https://doi.org/10.1161/hypertensionaha.121.18711

[32] Shi, Xiaoyan, Hanwen Huang, Min Zhou, Yarong Liu, Hongfei Wu, and Min Dai. 2021. “Paeonol Attenuated Vascular Fibrosis Through Regulating Treg/Th17 Balance in a Gut Microbiota-Dependent Manner.” Frontiers in Pharmacology 12: 765482. https://doi.org/10.3389/fphar.2021.765482

[33] Shandilya, Shruti, Sandeep Kumar, Niraj Kumar Jha, Kavindra Kumar Kesari, and Janne Ruokolainen. 2022. “Interplay of Gut Microbiota and Oxidative Stress: Perspective on Neurodegeneration and Neuroprotection.” Journal of Advanced Research 38: 223-244. https://doi.org/10.1016/j.jare.2021.09.005

[34] de Assis Gadelha, Danilo Duarte, José Luiz de Brito Alves, Paulo César Trindade da Costa, Mickael Sousa da Luz, Clênia de Oliveira Cavalcanti, Fabrícia França Bezerril, Juliana Franco Almeida, et al. 2024. “Lactobacillus Group and Arterial Hypertension: A Broad Review on Effects and Proposed Mechanisms.” Critical Reviews in Food Science and Nutrition 64: 3839-3860. https://doi.org/10.1080/10408398.2022.2136618

[35] Zhang, Qinren, Ning Meng, Yu Liu, Haiyan Zhao, Zhengtao Zhao, Dan Hao, Ruiding Li, et al. 2023. “Protection Effect of Gut Microbiota Composition and Acetate Absorption against Hypertension-Induced Damages on the Longevity Population in Guangxi, China.” Frontiers in Nutrition 9: 1070223. https://doi.org/10.3389/fnut.2022.1070223

[36] Lu, Dasheng, Shaodong Xu, Ping Dai, Lijuan Wu, Hongxiang Zhang, and Birong Zhou. 2022. “Gut Microbiota in Hypertensive Patients with Versus Without Obstructive Sleep Apnea.” The Journal of Clinical Hypertension 24: 1598-1605. https://doi.org/10.1111/jch.14598

[37] Wang, Wei, Liping Chen, Rui Zhou, Xiaobing Wang, Lu Song, Sha Huang, Ge Wang, and Bing Xia. 2014. “Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease.” Journal of Clinical Microbiology 52: 398-406. https://doi.org/10.1128/jcm.01500-13

[38] Hsu, Chien-Ning, Pei-Chen Lu, Mao-Hung Lo, I-Chun Lin, Guo-Ping Chang-Chien, Sufan Lin, and You-Lin Tain. 2018. “Gut Microbiota-Dependent Trimethylamine N-Oxide Pathway Associated with Cardiovascular Risk in Children with Early-Stage Chronic Kidney Disease.” International Journal of Molecular Sciences 19: 3699. https://doi.org/10.3390/ijms19123699

[39] Jiang, Shan, Yongjie Shui, Yu Cui, Chun Tang, Xiaohua Wang, Xingyu Qiu, Weipeng Hu, et al. 2021. “Gut Microbiota Dependent Trimethylamine N-Oxide Aggravates Angiotensin II-induced Hypertension.” Redox Biology 46: 102115. https://doi.org/10.1016/j.redox.2021.102115

[40] Aoyama, Norio, Jun-Ichi Suzuki, Hidetoshi Kumagai, Yuichi Ikeda, Hiroshi Akazawa, Issei Komuro, Masato Minabe, Yuichi Izumi, and Mitsuaki Isobe. 2018. “Specific Periodontopathic Bacterial Infection Affects Hypertension in Male Cardiovascular Disease Patients.” Heart and Vessels 33: 198-204. https://doi.org/10.1007/s00380-017-1042-z

[41] Ko, Chih-Yuan, An-Ke Hu, Dylan Chou, Li-Mei Huang, Huan-Zhang Su, Fu-Rong Yan, Xiao-Bin Zhang, Hua-Ping Zhang, and Yi-Ming Zeng. 2019. “Analysis of Oral Microbiota in Patients with Obstructive Sleep Apnea-Associated Hypertension.” Hypertension Research 42: 1692-1700. https://doi.org/10.1038/s41440-019-0260-4

[42] Su, Jie, Yajun Wang, Meiqiu Yan, Ziwen He, Yiqing Zhou, Jie Xu, Bo Li, et al. 2022. “The Beneficial Effects of Polygonatum Sibiricum Red. Superfine Powder on Metabolic Hypertensive Rats Via Gut-Derived LPS/TLR4 Pathway Inhibition.” Phytomedicine 106: 154404. https://doi.org/10.1016/j.phymed.2022.154404

[43] Prieto, Isabel, Marina Hidalgo, Ana Belén Segarra, Ana María Martínez-Rodríguez, Antonio Cobo, Manuel Ramírez, Hikmate Abriouel, Antonio Gálvez, and Magdalena Martínez-Cañamero. 2018. “Influence of a Diet Enriched with Virgin Olive Oil or Butter on Mouse Gut Microbiota and its Correlation to Physiological and Biochemical Parameters Related to Metabolic Syndrome.” PLoS One 13: e0190368. https://doi.org/10.1371/journal.pone.0190368

[44] Li, Huijun, Bingdong Liu, Jie Song, Zhen An, Xiang Zeng, Juan Li, Jing Jiang, Liwei Xie, and Weidong Wu. 2019. “Characteristics of Gut Microbiota in Patients with Hypertension and/or Hyperlipidemia: A Cross-Sectional Study on Rural Residents in Xinxiang County, Henan Province.” Microorganisms 7: 399. https://doi.org/10.3390/microorganisms7100399

[45] Pingili, Ajeeth K., Mehmet Kara, Nayaab S. Khan, Anne M. Estes, Zongtao Lin, Wei Li, Frank J. Gonzalez, and Kafait U. Malik. 2015. “6β-hydroxytestosterone, a Cytochrome P450 1B1 Metabolite of Testosterone, Contributes to Angiotensin II-induced Hypertension and its Pathogenesis in Male Mice.” Hypertension 65: 1279-1287. https://doi.org/10.1161/hypertensionaha.115.05396

[46] Pingili, Ajeeth K., Brett L. Jennings, Kamalika Mukherjee, Wadah Akroush, Frank J. Gonzalez, and Kafait U. Malik. 2020. “6β-Hydroxytestosterone, a Metabolite of Testosterone Generated by CYP1B1, Contributes to Vascular Changes in Angiotensin II-induced Hypertension in Male Mice.” Biology of Sex Differences 11: 4. https://doi.org/10.1186/s13293-019-0280-4

[47] Stevens, Lianne J., Marola M. H. van Lipzig, Steven L. A. Erpelinck, Apollo Pronk, Joost van Gorp, Heleen M. Wortelboer, and Evita van de Steeg. 2019. “A Higher Throughput and Physiologically Relevant Two-Compartmental Human Ex Vivo Intestinal Tissue System for Studying Gastrointestinal Processes.” European Journal of Pharmaceutical Sciences 137: 104989. https://doi.org/10.1016/j.ejps.2019.104989

[48] Hornych, A., M. Safar, J. Bariéty, A. Simon, C. Krief, and P. Milliez. 1982. “Urinary Thromboxane B2 in Hypertensive Patients.” Archives des Maladies du Coeur et des Vaisseaux 75(Spec No): 109-113.

[49] Chen, Long Shiung, Takayuki Ito, Kouichi Ogawa, Masahiko Shikano, and Tatsuo Satake. 1984. “Plasma Concentrations of 6-keto-prostaglandin F1 Alpha, Thromboxane B2 and Platelet Aggregation in Patients with Essential Hypertension.” Japanese Heart Journal 25: 1001-1009. https://doi.org/10.1536/ihj.25.1001

[50] Hu, Juan, Zhenzhen Yang, Xueqin Chen, Sujuan Kuang, Zhiwen Lian, Guibao Ke, Ruyi Liao, et al. 2021. “Thromboxane A(2) is Involved in the Development of Hypertension in Chronic Kidney Disease Rats.” European Journal of Pharmacology 909: 174435. https://doi.org/10.1016/j.ejphar.2021.174435

[51] Jasiczek, Jakub, Małgorzata Trocha, Arkadiusz Derkacz, Ewa Szahidewicz-Krupska, and Adrian Doroszko. 2021. “Effect of the Renin-Angiotensin-Aldosterone System Reactivity on Endothelial Function and Modulative Role of Valsartan in Male Subjects With Essential Hypertension.” Journal of Clinical Medicine 10: 5816. https://doi.org/10.3390/jcm10245816

[52] Kubo, Masato. 2020. “Diurnal Rhythmicity Programs of Microbiota and Transcriptional Oscillation of Circadian Regulator, NFIL3.” Frontiers in Immunology 11: 552188. https://doi.org/10.3389/fimmu.2020.552188

[53] Crislip, G. Ryan, Lauren G. Douma, Sarah H. Masten, Kit-Yan Cheng, I. Jeanette Lynch, Jermaine G. Johnston, Dominique Barral, et al. 2020. “Differences in Renal BMAL1 Contribution to Na(+) Homeostasis and Blood Pressure Control in Male and Female Mice.” American Journal of Physiology-Renal Physiology 318: F1463-F1477. https://doi.org/10.1152/ajprenal.00014.2020

[54] Fang, Zhengmei, Lijun Zhu, Yuelong Jin, Yan Chen, Weiwei Chang, and Yingshui Yao. 2021. “Downregulation of Arntl mRNA Expression in Women with Hypertension: A Case-Control Study.” Kidney & Blood Pressure Research 46: 741-748. https://doi.org/10.1159/000518669

[55] Stow, Lisa R., Jacob Richards, Kit-Yan Cheng, I. Jeanette Lynch, Lauren A. Jeffers, Megan M. Greenlee, Brian D. Cain, Charles S. Wingo, and Michelle L. Gumz. 2012. “The Circadian Protein Period 1 Contributes to Blood Pressure Control and Coordinately Regulates Renal Sodium Transport Genes.” Hypertension 59: 1151-1156. https://doi.org/10.1161/hypertensionaha.112.190892

[56] Tanaka, Sho, Takahiro Ueno, Akiko Tsunemi, Chinami Nagura, Kazunobu Tahira, Noboru Fukuda, Masayoshi Soma, and Masanori Abe. 2019. “The Adrenal Gland Circadian Clock Exhibits a Distinct Phase Advance in Spontaneously Hypertensive Rats.” Hypertension Research 42: 165-173. https://doi.org/10.1038/s41440-018-0148-8

[57] Zietara, Adrian, Denisha R. Spires, Alexandria Juffre, Hannah M. Costello, G. Ryan Crislip, Lauren G. Douma, Vladislav Levchenko, et al. 2022. “Knockout of the Circadian Clock Protein PER1 (Period1) Exacerbates Hypertension and Increases Kidney Injury in Dahl Salt-Sensitive Rats.” Hypertension 79: 2519-2529. https://doi.org/10.1161/hypertensionaha.122.19316

[58] Luan, Jiajie, Kui Yang, Yanyun Ding, Xiaotong Zhang, Yaqin Wang, Haiju Cui, Deixi Zhou, et al. 2022. “Valsartan-Mediated Chronotherapy in Spontaneously Hypertensive Rats via Targeting Clock Gene Expression in Vascular Smooth Muscle Cells.” Archives of Physiology and Biochemistry 128: 490-500. https://doi.org/10.1080/13813455.2019.1695840

[59] Li, Jing, Elaine M. Richards, Eileen M. Handberg, Carl J. Pepine, Eyad Alakrad, Chris E. Forsmark, and Mohan K. Raizada. 2023. “Influence of Butyrate on Impaired Gene Expression in Colon from Patients with High Blood Pressure.” International Journal of Molecular Sciences 24: 2650. https://doi.org/10.3390/ijms24032650

[60] Yuan, Ke, Ning-Yi Shao, Jan K. Hennigs, Marielle Discipulo, Mark E. Orcholski, Elya Shamskhou, Alice Richter, et al. 2016. “Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension.” The American Journal of Pathology 186: 2500-2514. https://doi.org/10.1016/j.ajpath.2016.05.016

[61] Patel, Sheila K., Jay Ramchand, Vincenzo Crocitti, and Louise M. Burrell. 2018. “Kruppel-Like Factor 15 is Critical for the Development of Left Ventricular Hypertrophy.” International Journal of Molecular Sciences 19: 1303. https://doi.org/10.3390/ijms19051303

[62] Patel, Sheila K., Elena Velkoska, Daniel Gayed, Jay Ramchand, Jessica Lesmana, and Louise M. Burrell. 2018. “Left Ventricular Hypertrophy in Experimental Chronic Kidney Disease is Associated with Reduced Expression of Cardiac Kruppel-Like Factor 15.” BMC Nephrology 19: 159. https://doi.org/10.1186/s12882-018-0955-9

[63] Yu, Mi-Yeon, Ji Eun Kim, Saram Lee, Jin Woo Choi, Yong Chul Kim, Seung Seok Han, Hajeong Lee, et al. 2020. “Krüppel-Like Factor 15 is a Key Suppressor of Podocyte Fibrosis Under Rotational Force-Driven Pressure.” Experimental Cell Research 386: 111706. https://doi.org/10.1016/j.yexcr.2019.111706

[64] Li, Xue-Ting, Jia-Wei Song, Zhen-zhou Zhang, Mi-Wen Zhang, Li-Rong Liang, Ran Miao, Ying Liu, et al. 2022. “Sirtuin 7 Mitigates Renal Ferroptosis, Fibrosis and Injury in Hypertensive Mice by Facilitating the KLF15/Nrf2 Signaling.” Free Radical Biology & Medicine 193: 459-473. https://doi.org/10.1016/j.freeradbiomed.2022.10.320

[65] Chekka, Lakshmi Manasa S., Marwa Tantawy, Taimour Langaee, Danxin Wang, Rolf Renne, Arlene B. Chapman, John G. Gums, et al. 2024. “Circulating microRNA Biomarkers of Thiazide Response in Hypertension.” Journal of the American Heart Association 13: e032433. https://doi.org/10.1161/jaha.123.032433

[66] Paeslack, Nadja, Maximilian Mimmler, Stefanie Becker, Zhenling Gao, My Phung Khuu, Amrit Mann, Frano Malinarich, Tommy Regen, and Christoph Reinhardt. 2022. “Microbiota-Derived Tryptophan Metabolites in Vascular Inflammation and Cardiovascular Disease.” Amino Acids 54: 1339-1356. https://doi.org/10.1007/s00726-022-03161-5

[67] Hsu, Chien-Ning, and You-Lin Tain. 2020. “Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism.” International Journal of Molecular Sciences 21: 8705. https://doi.org/10.3390/ijms21228705

[68] Bernal-Mizrachi, Carlos, Allison C. Gates, Sherry Weng, Takuji Imamura, Russell H. Knutsen, Pascual DeSantis, Trey Coleman, et al. 2005. “Vascular Respiratory Uncoupling Increases Blood Pressure and Atherosclerosis.” Nature 435: 502-506. https://doi.org/10.1038/nature03527

RIGHTS & PERMISSIONS

2024 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.